Eurofins Scient (OTCMKTS:ERFSF – Get Free Report)’s stock price reached a new 52-week high during trading on Wednesday. The company traded as high as $99.7980 and last traded at $99.7980, with a volume of 312 shares changing hands. The stock had previously closed at $98.2720.
Analyst Ratings Changes
Separately, Sanford C. Bernstein cut shares of Eurofins Scient from an “outperform” rating to a “hold” rating in a research report on Tuesday, September 29th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold”.
Read Our Latest Analysis on ERFSF
Eurofins Scient Trading Down 4.3%
The company has a quick ratio of 1.07, a current ratio of 1.13 and a debt-to-equity ratio of 0.80. The company has a 50 day moving average of $88.42 and a 200-day moving average of $79.73.
Eurofins Scient Company Profile
Eurofins Scientific SE is a Luxembourg-based international laboratory and testing services company. It provides analytical, inspection and certification services for the pharmaceutical, food, environmental, agricultural, consumer products and healthcare industries.
The company’s services include laboratory testing, product safety and quality analysis, environmental monitoring, pharmaceutical development and validation, genomic testing, clinical diagnostics, and agroscience services. Eurofins also supports companies and public-sector organizations with research, regulatory compliance and quality-control programs.
Founded in 1987 by Gilles Martin, Eurofins has expanded from its original focus on food testing into a broad network of laboratories and specialized testing businesses serving customers in Europe, North America, Asia-Pacific and other international markets.
See Also
- Five stocks we like better than Eurofins Scient
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.
